News/Press Releases

• Today, @AmerGeriatrics @HealthinAging announces Dr. Michael Devinney (@Mike_Devinney) as the 2024 recipient of the Jeffrey H. Silverstein Memorial Award for Emerging Investigators in the Surgical and Related Medical Specialties. https://ow.ly/Gwvy50Riaae

New York, NY (April 17, 2024) — The American Geriatrics Society (AGS) and the AGS Health in Aging Foundation today announced that Michael Devinney, MD, PhD Assistant Professor of Anesthesiology at Duke University as the 2024 recipient of the Jeffrey H. Silverstein Memorial Award for Emerging Investigators in the Surgical and Related Medical Specialties. 

• Members of the @AmCollSurgeons Geriatric Surgery Verification program team to present Henderson State-of-the-Art lecture during @AmerGeriatrics’ #AGS24 virtual annual meeting with a focus on how this program improves outcomes for older adults undergoing surgery.

• @AmerGeriatrics recognizes the Institute for Health Care Improvement @TheIHI for its work to advance age-friendly healthcare for all of us as we age with its 2024 David H. Solomon Memorial Public Service Award. https://ow.ly/t3kO50RcXjP

New York (4/11/2024) — Today, the American Geriatrics Society (AGS) announced that it will be honoring the Institute for Healthcare Improvement (IHI) with its David H.

• @amergeriatrics reaffirms ongoing commitment to just healthcare system by opposing policies that aim to eliminate diversity in medical education in statement released today. https://ow.ly/Tyot50ReATK

New York (April 11, 2024) — The American Geriatrics Society (AGS) remains committed to achieving a just healthcare system where the care a person receives is responsive to their individual needs and offered with cultural humility. 

• Today, the @AmerGeriatrics announced Joyce Fogel, MD as the 2024 recipient of the AGS Clinician of the Year award. #AGS24 https://ow.ly/rX8550Rbbh5

New York (April 9, 2024) — The American Geriatrics Society (AGS) today announced Joyce Fogel, MD, as 2024 Clinician of the Year. Dr.

• At #AGS24, Dr. C. Barrett Bowling (@barrett_bowling) to deliver Thomas and Catherine Yoshikawa Outstanding Scientific Achievement for Clinical Investigation Award Lecture on “Geriatricizing” Chronic Disease Research https://ow.ly/bvRg50R8mXe

New York (April 4, 2024) — Today, the American Geriatrics Society (AGS) and the AGS Health in Aging Foundation (HiAF) announced that the 2024 Thomas and Catherine Yoshikawa Award for Outstanding Scientific Achievement in Clinical Investigation will be awarded to C. Barrett Bowling, MD, MSPH, Associate Professor in the Division of Geriatrics at Duke University School of Medicine.

• At #AGS24, @AmerGeriatrics and #geriatrics experts cast a wide net for social & scientific innovations shaping better care for us all as we age. https://ow.ly/eqei50R66WZ

New York (April 1, 2024) – Researchers presenting at this year’s American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS24) to be held May 9 – 11 (pre-conference days: Tuesday & Wednesday, May 7-8) represent the best and brightest in geriatrics scholarship, with this year’s presentations drawn from a pool of more than 750 submissions. The presenters at this year’s prestigious #AGS24 Plenary Paper Session (Thurs., May 9 - 11:15 am – 12 pm EST) reflect the breadth and depth of research that is focused on improving the health and well-being of all of us as we age:

• Today, the AGS (@amergeriatrics) announced the results of recent AGS Board and Nominating Committee elections. See here for details: https://ow.ly/AeUC50QUFOP

New York (March 15, 2024) – Today, the American Geriatrics Society (AGS) announced the results of its recent AGS Board and Nominating Committee elections.

The AGS Board and Nominating Committee are comprised of geriatrics health professionals who are committed to improving health, independence and quality of life for all of us as we age. The following AGS Members were elected by AGS members:

Paul Mulhausen, MD, MHS, FACP AGSF, AGS President-Elect

• . @AmerGeriatrics supports the recently announced decision from the Centers for Medicare and Medicaid Services (CMS) to require the collection of real-world information via a registry to study monoclonal antibodies. Read more: https://www.americangeriatrics.org/media-center/news/ags-supports-cms-decision-require-real-world-data-monoclonal-antibodies

New York (July 11, 2023)  — The American Geriatrics Society (AGS) supports the recently announced decision from the Centers for Medicare and Medicaid Services (CMS) to require the collection of real-world information via a registry to study monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease. This decision applies to monoclonal antibodies that receive traditional approval from the Food and Drug Administration (FDA). Currently, lecanemab (trade name Leqembi™) is the only monoclonal antibody with this approval.

• Today, @AmerGeriatrics released the 2023 update to the AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults (DOI: 10.1111/jgs.18372). http://ow.ly/P0Q850Og2Zf

New York (May 4, 2023) — Today, the American Geriatrics Society (AGS) released the 2023 update to the AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults (DOI: 10.1111/jgs.18372). The AGS Beers Criteria® serves as a comprehensive list of medications that older people should potentially avoid or consider using with caution because they often present unnecessary risks for this population. Given that, according to the National Center for Health Statistics, United States (NCHSUS), more than 88% of older people use at least one prescription and more than 66% use three or more in any given month, the AGS Beers Criteria® are an important clinical, educational, and quality assurance tool for clinicians across disciplines and the healthcare system as a whole.